• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17976

【品名】(3R)-3-amino-1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,4(3H,5H)-dione

【CA登记号】

【 分 子 式 】C21H28N4O3

【 分 子 量 】384.47848

【元素组成】C 65.6% H 7.34% N 14.57% O 12.48%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XII)

2-nitroaniline (III) was prepared by reaction of an excess of cyclohexylamine (II) with either 2-chloronitrobenzene (Ia) in the presence of CuI and K2CO3 at 150 C or 2-fluoronitrobenzene (Ib) in chloroform. Catalytic hydrogenation gave phenylenediamine (IV), which was selectively alkylated on the primary N atom with bromoacetylpyrrolidine (V) in the presence of K2CO3 in DMF. Condensation of the resulting (VI) with the malonic acid dichloride (VII) yielded benzodiazepine (VIII). Hydrazone function was then reduced with zinc dust in acetic acid to provide amine (IX). Separation of the racemic mixture was performed by treatment with the chiral carbonic acid derivative (X), followed by chromatographic separation to give the desired (S)-isomer (XI). Cleavage of the carbamate group of (XI) was effected by hydrogenolysis to afford chiral amine (XII). The target urea was then prepared by reaction of (XII) with 4-fluorophenylisocyanate (XIII) in dichloromethane.

1 Bailey, N.; et al.; Novel 1,5-benzodiazepindione gastrin/CCKB antagonists. Bioorg Med Chem Lett 1997, 7, 3, 281.
2 Finch, H.; Shah, P.; Carr, R.A.E. (Glaxo Wellcome plc); 1,5-Benzodiazepine derivs. having CCK and/or gastrin antagonistic activity. US 5585376; US 5646140; WO 9424149; WO 9424151 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Ia) 17964 (2-chlorophenyl)(oxo)-lambda(5)-azanolate C6H5ClNO2 详情 详情
(Ib) 17965 (2-fluorophenyl)(oxo)-lambda(5)-azanolate C6H5FNO2 详情 详情
(II) 17966 cyclohexanamine; cyclohexyl amine; cyclohexylamine 108-91-8 C6H13N 详情 详情
(III) 17967 [2-(cyclohexylamino)phenyl](oxo)-lambda(5)-azanolate C12H17N2O2 详情 详情
(IV) 17968 N-(2-aminophenyl)-N-cyclohexylamine; N(1)-cyclohexyl-1,2-benzenediamine C12H18N2 详情 详情
(V) 17969 2-bromo-1-(1-pyrrolidinyl)-1-ethanone C6H10BrNO 详情 详情
(VI) 17970 2-[2-(cyclohexylamino)anilino]-1-(1-pyrrolidinyl)-1-ethanone C18H27N3O 详情 详情
(VII) 17971 2-(2-phenylhydrazono)malonoyl dichloride C9H6Cl2N2O2 详情 详情
(VIII) 17972 1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,3,4(5H)-trione 3-(N-phenylhydrazone) C27H31N5O3 详情 详情
(IX) 17973 3-amino-1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,4(3H,5H)-dione C21H28N4O3 详情 详情
(X) 17974 4-nitrophenyl (1S)-1-phenylethyl carbonate C15H13NO5 详情 详情
(XI) 17975 (1S)-1-phenylethyl (3R)-1-cyclohexyl-2,4-dioxo-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-ylcarbamate C30H36N4O5 详情 详情
(XII) 17976 (3R)-3-amino-1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,4(3H,5H)-dione C21H28N4O3 详情 详情
(XIII) 17977 1-Fluoro-4-isocyanatobenzene; 4-Fluorophenyl isocyanate 1195-45-5 C7H4FNO 详情 详情
Extended Information